Vaccines

Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) are likely to submit a request for an emergency use authorization to the U.S. Food and Drug Administration on Tuesday for a COVID-19 vaccine aimed at children younger than five years. What Happened: The vaccine, made by the two companies, will...

Novavax Inc (NASDAQ: NVAX) said Wednesday that Australia’s national drugs regulator has granted approval for its COVID-19 vaccine. What Happened: The Maryland-based biotechnology company said that Australia’s Therapeutic Goods Administration or TGA granted approval for provisional...

The hashtag “Boycott Starbucks” is trending on Twitter Inc.’s (NYSE: TWTR) social media platform in the U.S. after coffee chain Starbucks Corp. (NASDAQ: SBUX) suspended COVID-19 vaccine-or-test requirement for its U.S. employees. What Happened: The hashtag was among the top ten...

COVID-19 vaccine stocks are all retreating sharply for a second day running on Friday. The U.S. Supreme Court on Thursday ruled against President Joe Biden's quest to make it mandatory for large businesses employing over 100 people to have their staff vaccinated and undergo weekly testing...

Heading into a new trading week, here is a quick roundup of the top five stories from the technology, corporate and cryptocurrency sectors that investors would not want to miss out on from the weekend. 1. Elon Musk Urges Tesla Workers To Reduce Delivery Costs: Tesla Inc. (NASDAQ: TSLA) CEO Elon...

Moderna Inc (NASDAQ: MRNA) is having a strong start to the week, up more than 7% Monday on heavy volume. Thus far, the stock has traded over 11 million shares versus its 10 day average of 8 million. What Happened: The stock received positive news late last week as it was granted...

Moderna Inc (NASDAQ: MRNA) shares are trading lower Thursday after the company announced its COVID-19 sales came in short of Wall Street analysts estimates by more than $1 billion. The company reported $5 billion in revenue for the third quarter of the year, missing the analyst...

Moderna: Look Out Below? COVID-19 vaccine maker Moderna, Inc. (NASDAQ: MRNA) was our top name in late August... Screen capture via Portfolio Armor on 8/26/2021. But it has tumbled since, down almost 17% as of Wednesday's close.  Strong returns from the oil E&P Laredo...

The U.S. Food and Drug Administration on Wednesday approved booster shots of Moderna Inc.’s (NASDAQ: MRNA) and Jonson & Johnson’s (NYSE: JNJ) COVID-19 vaccines as well as authorized “mixing and matching” of the booster doses. What Happened: The FDA said it has approved...

Shares of biopharmaceutical company Ocugen Inc. (NASDAQ: OCGN) surged almost 18.5% in Tuesday’s regular trading session, extending gains to a second straight day. What Happened: Ocugen’s shares extended their rally on Tuesday after it was reported that an expert panel of India’s...

With the state of New South Wales, including capital Sydney, officially marking an end to its 106-day lockdown, certain small business owners have decided to remain closed, with restaurants only offering takeaway services. The decision was made in response to the new mandate in place,...

TSA Checkpoints For COVID Vaccines? Our pseudonymous Twitter correspondent Benjamin Braddock wrote a thought-provoking post about the parallels between the federal government's restriction of civil liberties post-9/11 and the current pressure to require proof of vaccination. We've posted it...

Pfizer Inc (NYSE: PFE) and its partner BioNTech SE’s (NASDAQ: BNTX) COVID-19 vaccine’s effectiveness against the disease wanes with time but its protection against hospitalization remains, as per a study. What Happened: The vaccine’s effectiveness declined from a peak of 88% a...

Moderna Inc (NASDAQ: MRNA) stock is trading at its lowest level since late July. This once high-flying stock that notched up stratospheric gains from its COVID-19 program has lost altitude. The Breathtaking Tally Hits The Pause: Moderna shares soared over 430% in 2020...

Pfizer Inc (NYSE: PFE) CEO Albert Bourla said that there is a likelihood that annual booster shots of the coronavirus vaccine will be needed. What Happened: Bourla said in an interview with ABC’s “This Week” program that the COVID-19 vaccine could morph into an annual shot. ...